Riggs Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Riggs Asset Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-139	Closed	-$11.1K	–	458
2023 Q3	$11.1K	Sell	139 -4,229	-97%	-$341K	﹤0.01%	233
2023 Q2	$344K	Sell	4,368 -489	-10%	-$38.3K	0.12%	80
2023 Q1	$377K	Sell	4,857 -119	-2%	-$9.17K	0.15%	78
2022 Q4	$387K	Sell	4,976 -187	-4%	-$13.8K	0.16%	77
2022 Q3	$347K	Buy	5,163 +30	+0.6%	+$2.21K	0.14%	75
2022 Q2	$394K	Buy	+5,133	New	+$401K	0.16%	69

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Riggs Asset Management's PPH Position: Q4 2023 in Review

Riggs Asset Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2023, closing a stake of 139 shares — an estimated $11.1K sold.

Riggs Asset Management first reported a position in PPH in Q2 2022 and held it in 6 quarters. The position peaked at $394K in Q2 2022. 110 funds tracked by Wall St. Rank hold PPH as of Q4 2023.

Riggs Asset Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2023 after selling out during the quarter.
Riggs Asset Management sold 139 VanEck Pharmaceutical ETF shares in Q4 2023, an estimated $11.1K.
Riggs Asset Management first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 6 quarters.
Riggs Asset Management's VanEck Pharmaceutical ETF position peaked at $394K in Q2 2022.
110 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2023.

Based on Riggs Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.